EP3116531
PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.3.2015EP published:
20.10.2021EP application number:
15761797.8
EPO information:
European Patent Register
Max expiry date:
10.3.2035
Title:
PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE
Timeline
Today
11.3.2015EP application
20.10.2021EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Inventor
Name:
ORTIGOSA, Allison, D.Address:
Elkton, Virginia 22827, US
Name:
COLEMAN, Michael, P.Address:
West Point, Pennsylvania 19486, US
Name:
GEORGE, Shibu, T.Address:
Boulder, Colorado 80301, US
Name:
RAUSCHER, Michael, A.Address:
Kenilworth, New Jersey 07033, US
Name:
SLEEVI, Mark, C.Address:
Boulder, Colorado 80301, US
Name:
CHOW, KartoaAddress:
San Francisco, California 94102, US
Priority
Number:
201461953001 PDate:
14.3.2014Country:
US
Classification
Categories:
A61K 38/28, A61K 38/00, C07K 1/00